JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Additional Paid In Capital
JCR Pharmaceuticals Co Ltd
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Additional Paid In Capital
¥10.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Additional Paid In Capital
¥1.7T
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
46%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Additional Paid In Capital
¥2B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-33%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Additional Paid In Capital
¥506.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Additional Paid In Capital
¥69.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Astellas Pharma Inc
TSE:4503
|
Additional Paid In Capital
¥184.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
10.4B
JPY
Based on the financial report for Mar 31, 2024, JCR Pharmaceuticals Co Ltd's Additional Paid In Capital amounts to 10.4B JPY.
What is JCR Pharmaceuticals Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-1%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for JCR Pharmaceuticals Co Ltd have been -2% over the past three years , -1% over the past five years , and -1% over the past ten years .